nanoMesh

nanoMesh is a private U.S. medical device company formed by Exogenesis Corporation to commercialize a proprietary hernia repair mesh product. Its lead and apparently sole marketed product is Exogenesis Hernia Mesh, a monofilament polypropylene surgical mesh whose surface is modified using Exogenesis's Accelerated Neutral Atom Beam (ANAB) nanostructuring technology. The product is intended for repair of abdominal wall hernia defects, including inguinal hernias, and the company announced first-in-man implantation and U.S. commercial availability in 2021. nanoMesh appears to operate as a focused commercial vehicle rather than a broad therapeutics developer, centered on soft-tissue repair implants and line extensions of the nanoMesh product family.